Lenvatinib Mesylate
- CAS No.857890-39-2:
- Molecular Formula:C22H23ClN4O7S:
- Molecular Weight:523.0:
- Reference Standard:In-house:
- Documentation:China DMF:
- Inquiry
Product Description
Lenvatinib Mesylate is a synthetic, orally available inhibitor of vascular endothelial growth factor receptor 2 (VEGFR2, also known as KDR/FLK-1) tyrosine kinase with potential antineoplastic activity. E7080 blocks VEGFR2 activation by VEGF, resulting in inhibition of the VEGF receptor signal transduction pathway, decreased vascular endothelial cell migration and proliferation, and vascular endothelial cell apoptosis.
Hits: 【Print】